ZNF736P2Y
associated omics dataQ-omics provides the consensus-scored ZNF736P2Y profile across patient tissues and cancer cell-line models. ZNF736P2Y expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in BRCA.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for ZNF736P2Y — synthetic lethality, tumor antigen, and pembrolizumab response.
View premium →Survival associations
This table summarizes ZNF736P2Y survival associations across molecular data types. ZNF736P2Y RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible ZNF736P2Y RNA expression–survival associations across cancer types. High ZNF736P2Y expression shows unfavorable associations in BRCA. The BRCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .004). Together, the overview and detailed table identify BRCA as the clearest survival context for ZNF736P2Y RNA expression.
